AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35176046 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 360
Study 33619917 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-lasting permethrin impregnated (LLPI) socks
Number of subjects: 367
Study 33619917 — intervention group
Group type: COMPARATOR
Intervention: General socks
Number of subjects: 367
Study 32941462 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive electronic-consultation from pulmonologists recommending ICS discontinuation
Number of subjects: 9
Study 32941462 — intervention group
Group type: COMPARATOR
Intervention: Unexposed providers' anticipation of patient resistance to ICS discontinuation
Number of subjects: 9
Study 32941462 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention-exposed providers' experiences post-intervention
Number of subjects: 9
Study 35525420 — intervention group
Group type: EXPERIMENTAL
Intervention: Chrononutritional and sleep hygiene intervention
Number of subjects: 103
Study 35525420 — intervention group
Group type: COMPARATOR
Intervention: Usual care for gestational diabetes mellitus
Number of subjects: 103
Study 34409989 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 1051
Study 36345138 — intervention group
Group type: EXPERIMENTAL
Intervention: +10% increased cadence
Number of subjects: 48
Study 36345138 — intervention group
Group type: EXPERIMENTAL
Intervention: ‐10% decreased cadence
Number of subjects: 48
Study 36345138 — intervention group
Group type: COMPARATOR
Intervention: Preferred cadence
Number of subjects: 48
Study 33951613 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitors (PPIs)
Number of subjects: 5594
Study 32839161 — intervention group
Group type: EXPERIMENTAL
Intervention: GP-targeted educational intervention
Number of subjects: 224
Study 32839161 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 224
Study 35674828 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) supplementation
Number of subjects: 20
Study 35674828 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 32338886 — intervention group
Group type: EXPERIMENTAL
Intervention: Ball milling grinding process
Number of subjects: 1
Study 32338886 — intervention group
Group type: COMPARATOR
Intervention: Control (non-milled)
Number of subjects: 1
Study 33166213 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar iTBS with physiotherapy
Number of subjects: 30
Study 33166213 — intervention group
Group type: COMPARATOR
Intervention: Sham iTBS with physiotherapy
Number of subjects: 30
Study 33052404 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovering Together (RT)
Number of subjects: 58
Study 33052404 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 58
Study 35013909 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction
Number of subjects: 88
Study 35013909 — intervention group
Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 88
Study 35013909 — intervention group
Group type: COMPARATOR
Intervention: Caloric restriction and exercise interaction
Number of subjects: 88
Study 35013909 — intervention group
Group type: COMPARATOR
Intervention: Biomarker index correlation with physical performance
Number of subjects: 88
Study 35013909 — intervention group
Group type: COMPARATOR
Intervention: Biomarker index reduction and walking speed
Number of subjects: 88
Study 34371478 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin administration
Number of subjects: 39
Study 34371478 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 32426759 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute wild blueberry intervention
Number of subjects: 0
Study 34092524 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior nasal neurectomy + pharyngeal neurectomy
Number of subjects: 52
Study 34092524 — intervention group
Group type: COMPARATOR
Intervention: Posterior nasal neurectomy
Number of subjects: 52
Study 33789482 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 120
Study 33789482 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 120
Study 35260218 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypical antipsychotics
Number of subjects: 109
Study 33836161 — intervention group
Group type: EXPERIMENTAL
Intervention: Benznidazole 300 mg daily for 8 weeks
Number of subjects: 210
Study 33836161 — intervention group
Group type: EXPERIMENTAL
Intervention: Benznidazole 300 mg daily for 4 weeks
Number of subjects: 210
Study 33836161 — intervention group
Group type: EXPERIMENTAL
Intervention: Benznidazole 300 mg daily for 2 weeks
Number of subjects: 210
Study 33836161 — intervention group
Group type: EXPERIMENTAL
Intervention: Benznidazole 150 mg daily for 4 weeks
Number of subjects: 210
Study 33836161 — intervention group
Group type: EXPERIMENTAL
Intervention: Benznidazole 150 mg daily for 4 weeks plus fosravuconazole
Number of subjects: 210
Study 33836161 — intervention group
Group type: EXPERIMENTAL
Intervention: Benznidazole 300 mg weekly for 8 weeks plus fosravuconazole
Number of subjects: 210
Study 33836161 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study 32176245 — intervention group
Group type: EXPERIMENTAL
Intervention: Family member detention or deportation in the past year
Number of subjects: 547
Study 616864697 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannatide, oxaliplatin, and docetaxel sequential therapy
Number of subjects: 72
Study 616864697 — intervention group
Group type: COMPARATOR
Intervention: Thymosin, oxaliplatin, and docetaxel sequential therapy
Number of subjects: 72
Study 35703413 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-assisted interpretation
Number of subjects: 390
Study 35703413 — intervention group
Group type: COMPARATOR
Intervention: Non-AI-assisted interpretation
Number of subjects: 390
Study 34116913 — intervention group
Group type: EXPERIMENTAL
Intervention: Onlay patellar resurfacing technique
Number of subjects: 222
Study 34116913 — intervention group
Group type: COMPARATOR
Intervention: Inlay patellar resurfacing technique
Number of subjects: 222
Study 32757822 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure (rotary massage using the thumb at pressure points) for 4 weeks, 3 times a week for 20 minutes each session
Number of subjects: 72
Study 32757822 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 72
Study 35973032 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 139
Study 35973032 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 139
Study 34526081 — intervention group
Group type: EXPERIMENTAL
Intervention: Raw natural honey (0.5 g) and encapsulated organic Nigella sativa seeds (40 mg) per kg body weight per day
Number of subjects: 1000
Study 34526081 — intervention group
Group type: COMPARATOR
Intervention: Placebo (empty capsule with 30 ml of 5% dextrose water)
Number of subjects: 1000
Study 34526081 — intervention group
Group type: EXPERIMENTAL
Intervention: Raw natural honey and Nigella sativa
Number of subjects: 1000
Study 34526081 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study 32444057 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) program, 8 two-hour group sessions once a week.
Number of subjects: 36
Study 32444057 — intervention group
Group type: COMPARATOR
Intervention: Routine consultation (Control group)
Number of subjects: 36
Study 32444057 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) program
Number of subjects: 36
Study 36206399 — intervention group
Group type: EXPERIMENTAL
Intervention: Age increase by 10 years
Number of subjects: 100
Study 36206399 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapy duration >= 1 year
Number of subjects: 100
Study 35152767 — intervention group
Group type: EXPERIMENTAL
Intervention: Go NAPSACC intervention
Number of subjects: 3883
Study 32143392 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain Breaks® videos during classroom sessions for four months
Number of subjects: 3036
Study 32143392 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 3036
Study 34498386 — intervention group
Group type: EXPERIMENTAL
Intervention: BRAVA intervention
Number of subjects: 46
Study 34444671 — intervention group
Group type: EXPERIMENTAL
Intervention: S. boulardii and Superoxide Dismutase (SOD) supplementation for 60 days
Number of subjects: 25
Study 34444671 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 36387994 — intervention group
Group type: EXPERIMENTAL
Intervention: Online support program (monitoring app, confirmation app, writing app)
Number of subjects: 0
Study 36387994 — intervention group
Group type: COMPARATOR
Intervention: Monitoring app (control group)
Number of subjects: 0
Study 32282564 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure on 6 acupoints administered at home every night for 4 weeks
Number of subjects: 0
Study 32282564 — intervention group
Group type: COMPARATOR
Intervention: Control group maintained their daily routine
Number of subjects: 0
Study 34266843 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-threshold unguided digital self-management tool (transdiagnostic mental health app)
Number of subjects: 1100
Study 34266843 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 1100
Study 32088687 — intervention group
Group type: EXPERIMENTAL
Intervention: Infection control pathway (experimental group)
Number of subjects: 426
Study 33608835 — intervention group
Group type: EXPERIMENTAL
Intervention: Warming at 42 °C after vitrification in sterile liquid air (LA42)
Number of subjects: 0
Study 33608835 — intervention group
Group type: EXPERIMENTAL
Intervention: Warming at 45 °C after vitrification in sterile liquid air (LA45)
Number of subjects: 0
Study 33608835 — intervention group
Group type: COMPARATOR
Intervention: Vitrification in liquid nitrogen (LN) warmed at 42 °C
Number of subjects: 0
Study 34781981 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (400 mg daily for the first four days, then 400 mg weekly)
Number of subjects: 269
Study 34781981 — intervention group
Group type: COMPARATOR
Intervention: Placebo (same treatment schedule as hydroxychloroquine)
Number of subjects: 269
Study 34781981 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 269
Study 34781981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269
Study 34781981 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine and Placebo
Number of subjects: 269
Study 32205067 — intervention group
Group type: EXPERIMENTAL
Intervention: OCT-guided PCI
Number of subjects: 38
Study 32205067 — intervention group
Group type: COMPARATOR
Intervention: Angiography-guided PCI
Number of subjects: 38
Study 35403573 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of labour in week 41
Number of subjects: 12
Study 35403573 — intervention group
Group type: COMPARATOR
Intervention: Expectant management until week 42
Number of subjects: 12
Study 32857730 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure applied to P6 point, 3 times a day for 1 week
Number of subjects: 149
Study 32857730 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 149
Study 36078621 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic band resistance training (hip and chest regions)
Number of subjects: 23
Study 36078621 — intervention group
Group type: EXPERIMENTAL
Intervention: Participant feedback on the PA interventions
Number of subjects: 23
Study 36361372 — intervention group
Group type: EXPERIMENTAL
Intervention: READY-Nepal intervention
Number of subjects: 102
Study 36361372 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 102
Study 33579340 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant proton radiotherapy (39 Gy in 13 fractions)
Number of subjects: 0
Study 33579340 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant carbon ion radiotherapy (39 Gy in 13 fractions)
Number of subjects: 0
Study 33579340 — intervention group
Group type: COMPARATOR
Intervention: Combined treatment (neoadjuvant radiotherapy + surgery)
Number of subjects: 0
Study 33007908 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media
Number of subjects: 550
Study 33007908 — intervention group
Group type: COMPARATOR
Intervention: Traditional media
Number of subjects: 550
Study 35608666 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 70
Study 35608666 — intervention group
Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 70
Study 34228735 — intervention group
Group type: EXPERIMENTAL
Intervention: QUiPP app with admission, antenatal corticosteroids (ACSs), and transfer advised for women with a QUiPP risk of delivery >5% within 7 days.
Number of subjects: 1872
Study 34228735 — intervention group
Group type: EXPERIMENTAL
Intervention: QUiPP app
Number of subjects: 1872
Study 34228735 — intervention group
Group type: COMPARATOR
Intervention: Conventional management of TPTL at control sites.
Number of subjects: 1872
Study 34228735 — intervention group
Group type: COMPARATOR
Intervention: Control sites
Number of subjects: 1872
Study 35083027 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive nursing intervention
Number of subjects: 99
Study 35083027 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 99
Study 33749976 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to biological metrics of Life's Simple 7 (LS7)
Number of subjects: 229976
Study 33749976 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically elevated blood pressure
Number of subjects: 229976
Study 32191198 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care testing (POCT)
Number of subjects: 248
Study 32191198 — intervention group
Group type: COMPARATOR
Intervention: Central laboratory testing (CLT)
Number of subjects: 248
Study 36162898 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Decision Support (CDS) system
Number of subjects: 56
Study 36162898 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 56
Study 32842769 — intervention group
Group type: EXPERIMENTAL
Intervention: HoLEP (Versa pulse® 100 W; n=73)
Number of subjects: 145
Study 32842769 — intervention group
Group type: COMPARATOR
Intervention: BPRP (AUTOCON® II 400 ESU; n=72)
Number of subjects: 145
Study 32842769 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HoLEP and BPRP
Number of subjects: 145
Study 32842769 — intervention group
Group type: EXPERIMENTAL
Intervention: HoLEP
Number of subjects: 145
Study 34693583 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote monitoring and feedback using a smartphone application
Number of subjects: 40
Study 34693583 — intervention group
Group type: COMPARATOR
Intervention: Unmonitored period (control)
Number of subjects: 40
Study 32221084 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine combined with western medicine (ESWL treatment and TCM therapy)
Number of subjects: 100
Study 32221084 — intervention group
Group type: COMPARATOR
Intervention: Conventional drug treatment (control group)
Number of subjects: 100
Study 36134468 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed Facebook group for PPIE
Number of subjects: 289
Study 33760428 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral health reentry intervention (details not specified)
Number of subjects: 327
Study 32803900 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly exenatide (EQW)
Number of subjects: 3503
Study 32803900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3503
Study 34985309 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose DOAC
Number of subjects: 71683
Study 34985309 — intervention group
Group type: COMPARATOR
Intervention: Lower-dose DOAC
Number of subjects: 71683
Study 32891639 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathway group (NEEW + enhanced recovery after surgery)
Number of subjects: 192
Study 33322340 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Protein Diet (LPD) - 5% protein
Number of subjects: 23
Study 35507322 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP (Pre-exposure prophylaxis)
Number of subjects: 33
Study 33528930 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous immunotherapy with allergens (SCITA)
Number of subjects: 46
Study 36342119 — intervention group
Group type: EXPERIMENTAL
Intervention: Device-based temperature control targeting 36°C for 24 hours followed by targeting of 37°C for 12 hours (total 36 hours)
Number of subjects: 789
Study 36342119 — intervention group
Group type: EXPERIMENTAL
Intervention: Device-based temperature control targeting 36°C for 24 hours followed by targeting of 37°C for 48 hours (total 72 hours)
Number of subjects: 789
Study 36342119 — intervention group
Group type: EXPERIMENTAL
Intervention: Device-based temperature control for 36 hours
Number of subjects: 789
Study 36342119 — intervention group
Group type: EXPERIMENTAL
Intervention: Device-based temperature control for 72 hours
Number of subjects: 789
Study 34192298 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined epidural-general anesthesia and epidural analgesia
Number of subjects: 400
Study 34192298 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia alone
Number of subjects: 400
Study 35033600 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusion radiomic model
Number of subjects: 134
Study 35033600 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinicoradiomic model
Number of subjects: 134
Study 35033600 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomic model and clinicoradiomic model
Number of subjects: 134
Study 32734732 — intervention group
Group type: EXPERIMENTAL
Intervention: Active air purifiers with HEPA filters
Number of subjects: 0
Study 32734732 — intervention group
Group type: COMPARATOR
Intervention: Placebo air purifiers
Number of subjects: 0
Study 32097166 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting SPLD risk
Number of subjects: 2071
Study 32097166 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival (OS)
Number of subjects: 2071
Study 32097166 — intervention group
Group type: COMPARATOR
Intervention: Nomogram compared to Child-Pugh, MELD, ALBI, and EASL algorithm
Number of subjects: 2071
Study 33237618 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermic Oxygenated Perfusion (HOPE)
Number of subjects: 25
Study 36114466 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral ultrasound-guided erector spinae plane (ESP) block
Number of subjects: 47
Study 36114466 — intervention group
Group type: COMPARATOR
Intervention: Superficial parasternal intercostal plane (S-PIP) plus ESP block
Number of subjects: 47
Study 36114466 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 47
Study 34304268 — intervention group
Group type: EXPERIMENTAL
Intervention: MoveMore intervention plus usual care (UC)
Number of subjects: 153
Study 34304268 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) only
Number of subjects: 153
Study 32118304 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgically managed (SX)
Number of subjects: 98
Study 32118304 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgically managed (non-SX)
Number of subjects: 98
Study 32118304 — intervention group
Group type: COMPARATOR
Intervention: Unexposed horses
Number of subjects: 98
Study 35428653 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 Gy in 10 fractions over two weeks (arm A)
Number of subjects: 95
Study 35428653 — intervention group
Group type: COMPARATOR
Intervention: 20 Gy in 5 fractions over one week (arm B)
Number of subjects: 95
Study 33481449 — intervention group
Group type: EXPERIMENTAL
Intervention: HU-014
Number of subjects: 267
Study 33481449 — intervention group
Group type: COMPARATOR
Intervention: Onabotulinumtoxin A
Number of subjects: 267
Study 33481449 — intervention group
Group type: EXPERIMENTAL
Intervention: HU-014 and Onabotulinumtoxin A
Number of subjects: 267
Study 33778830 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraction site preservation (experimental group)
Number of subjects: 85
Study 33778830 — intervention group
Group type: COMPARATOR
Intervention: Routine tooth extraction (control group)
Number of subjects: 85
Study 36288428 — intervention group
Group type: EXPERIMENTAL
Intervention: Active air cleaner
Number of subjects: 85
Study 36288428 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 85
Study 34423994 — intervention group
Group type: EXPERIMENTAL
Intervention: Distance learning context
Number of subjects: 60
Study 34423994 — intervention group
Group type: COMPARATOR
Intervention: In-person classroom context
Number of subjects: 60
Study 34423994 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear of COVID-19
Number of subjects: 60
Study 32894145 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth plan implementation training session at weeks 32-36 of gestation
Number of subjects: 106
Study 32894145 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 106
Study 35435087 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma gel
Number of subjects: 27
Study 35435087 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma fluid
Number of subjects: 27
Study 35435087 — intervention group
Group type: COMPARATOR
Intervention: Control (Plasma gel vs Plasma fluid)
Number of subjects: 27
Study 33900137 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompressive surgery
Number of subjects: 0
Study 33900137 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32758407 — intervention group
Group type: EXPERIMENTAL
Intervention: Sternotomy group (15 patients) received 0.25% bupivacaine subcutaneous infiltration.
Number of subjects: 30
Study 32758407 — intervention group
Group type: COMPARATOR
Intervention: Thoracotomy group (15 patients) with 11 receiving fascial plane block and 3 receiving subcutaneous infiltration.
Number of subjects: 30
Study 32758407 — intervention group
Group type: COMPARATOR
Intervention: Thoracotomy group
Number of subjects: 30
Study 32758407 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 34731062 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive counseling (individual sessions and telephone consultation)
Number of subjects: 166
Study 35545982 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to 440Hz music
Number of subjects: 54